| __timestamp | ACADIA Pharmaceuticals Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 15635076 |
| Thursday, January 1, 2015 | 73869000 | 23943601 |
| Friday, January 1, 2016 | 99284000 | 23689111 |
| Sunday, January 1, 2017 | 149189000 | 41006114 |
| Monday, January 1, 2018 | 187163000 | 51379106 |
| Tuesday, January 1, 2019 | 240385000 | 32705593 |
| Wednesday, January 1, 2020 | 319130000 | 53274000 |
| Friday, January 1, 2021 | 239415000 | 85352000 |
| Saturday, January 1, 2022 | 361575000 | 51999000 |
| Sunday, January 1, 2023 | 351619000 | 59471000 |
In pursuit of knowledge
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, ACADIA Pharmaceuticals Inc. and Summit Therapeutics Inc. have demonstrated contrasting approaches to research and development (R&D) investments. From 2014 to 2023, ACADIA Pharmaceuticals consistently outpaced Summit Therapeutics in R&D spending, with an average annual investment nearly five times greater. In 2022, ACADIA's R&D expenses peaked at approximately $362 million, a staggering 600% increase from 2014. Meanwhile, Summit Therapeutics showed a more modest growth, with R&D expenses rising by about 280% over the same period. This disparity highlights ACADIA's aggressive strategy to drive innovation and maintain a competitive edge. As the biotech landscape evolves, these investment trends may shape the future breakthroughs in medical science.
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending